Publication | Closed Access
Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine?
15
Citations
10
References
2011
Year
Hematological MalignancyBone Marrow FailureDoes AdditionHigher-risk Myelodysplastic SyndromesMalignant Blood DisorderHematologyPharmacotherapyMedicineAplastic AnemiaMyeloid Neoplasia
| Year | Citations | |
|---|---|---|
Page 1
Page 1